Publication
Number of items: 4.
None
Increases in non-N-methyl-D-aspartate glutamatergic transmission, but no change in gamma-aminobutyric acid(B) transmission, in CA1 neurons during withdrawal from in-vivo chronic ethanol treatment. (1995)
A. Molleman
and
H.J. Little
Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils. (2012)
Roy Pettipher,
Shan L. Vinall,
Luzheng Xue,
Graham Speight,
Elizabeth R. Townsend,
Lucien Gazi,
C.J. Whelan,
Richard E. Armer,
Mark A. Payton
and
Michael G. Hunter
Separation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes. (1995)
C. R. Albrightson,
P. J. Bugelski,
Theo Berkhout,
B. Jackson,
William D. Kerns,
A.J. Organ
and
A. M. Badger
In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\increased motor disability. (2006)
Mahmoud M. Iravani,
Kayhan Tayarani-Binazir,
Wing B. Chu,
Michael J. Jackson
and
Peter Jenner